143 related articles for article (PubMed ID: 8057302)
1. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.
Cruciani G; Watson KA
J Med Chem; 1994 Aug; 37(16):2589-601. PubMed ID: 8057302
[TBL] [Abstract][Full Text] [Related]
2. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
Venkatarangan P; Hopfinger AJ
J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.
Menezes IR; Lopes JC; Montanari CA; Oliva G; Pavão F; Castilho MS; Vieira PC; Pupo MT
J Comput Aided Mol Des; 2003; 17(5-6):277-90. PubMed ID: 14635721
[TBL] [Abstract][Full Text] [Related]
4. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
[TBL] [Abstract][Full Text] [Related]
5. A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis.
Pastor M; Cruciani G; Watson KA
J Med Chem; 1997 Dec; 40(25):4089-102. PubMed ID: 9406599
[TBL] [Abstract][Full Text] [Related]
6. Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.
Sippl W
J Comput Aided Mol Des; 2000 Aug; 14(6):559-72. PubMed ID: 10921772
[TBL] [Abstract][Full Text] [Related]
7. Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors.
Ortiz AR; Pastor M; Palomer A; Cruciani G; Gago F; Wade RC
J Med Chem; 1997 Mar; 40(7):1136-48. PubMed ID: 9089335
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors.
So SS; Karplus M
J Comput Aided Mol Des; 1999 May; 13(3):243-58. PubMed ID: 10216832
[TBL] [Abstract][Full Text] [Related]
9. Grid-based Continual Analysis of Molecular Interior for Drug Discovery, QSAR and QSPR.
Potemkin AV; Grishina MA; Potemkin VA
Curr Drug Discov Technol; 2017; 14(3):181-205. PubMed ID: 28176631
[TBL] [Abstract][Full Text] [Related]
10. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors.
Pastor M; Cruciani G; McLay I; Pickett S; Clementi S
J Med Chem; 2000 Aug; 43(17):3233-43. PubMed ID: 10966742
[TBL] [Abstract][Full Text] [Related]
11. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
12. Development of biologically active compounds by combining 3D QSAR and structure-based design methods.
Sippl W
J Comput Aided Mol Des; 2002 Nov; 16(11):825-30. PubMed ID: 12825795
[TBL] [Abstract][Full Text] [Related]
13. GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype.
Nilsson J; Wikström H; Smilde A; Glase S; Pugsley T; Cruciani G; Pastor M; Clementi S
J Med Chem; 1997 Mar; 40(6):833-40. PubMed ID: 9083471
[TBL] [Abstract][Full Text] [Related]
14. Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships.
Pastor M; Cruciani G; Clementi S
J Med Chem; 1997 May; 40(10):1455-64. PubMed ID: 9154968
[TBL] [Abstract][Full Text] [Related]
15. Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
Watson KA; Mitchell EP; Johnson LN; Son JC; Bichard CJ; Orchard MG; Fleet GW; Oikonomakos NG; Leonidas DD; Kontou M
Biochemistry; 1994 May; 33(19):5745-58. PubMed ID: 8180201
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
Pan D; Tseng Y; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(5):1591-607. PubMed ID: 14502494
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.
So SS; Karplus M
J Comput Aided Mol Des; 2001 Jul; 15(7):613-47. PubMed ID: 11688944
[TBL] [Abstract][Full Text] [Related]
18. New approach to pharmacophore mapping and QSAR analysis using inductive logic programming. Application to thermolysin inhibitors and glycogen phosphorylase B inhibitors.
Marchand-Geneste N; Watson KA; Alsberg BK; King RD
J Med Chem; 2002 Jan; 45(2):399-409. PubMed ID: 11784144
[TBL] [Abstract][Full Text] [Related]
19. GA strategy for variable selection in QSAR studies: application of GA-based region selection to a 3D-QSAR study of acetylcholinesterase inhibitors.
Hasegawa K; Kimura T; Funatsu K
J Chem Inf Comput Sci; 1999; 39(1):112-20. PubMed ID: 10094610
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
Waller CL; Oprea TI; Giolitti A; Marshall GR
J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
